Bullfrog AI Holdings, Inc. (BFRG) shares surged 126.24 percent, up $0.6417 to $1.1500 on Monday, after the company announced a commercial agreement with a top five global pharmaceutical company to apply its bfLEAP platform to identify and prioritize novel drug targets for major depressive disorder, supporting the partner's drug discovery and clinical development program.
The stock is currently trading at $1.1500, above its previous close of $0.5083, after opening at $1.0500 on the Nasdaq. Shares traded in a range of $0.9820 to $1.3600 during the session, with volume soaring to 192.58 million shares, far above the average daily volume of 0.69 million.
The agreement also grants the pharmaceutical partner exclusive access to a target candidate, while the company said additional terms will be disclosed in a filing with the U.S. Securities and Exchange Commission. BullFrog AI's 52-week range is $0.4250 to $2.2000.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.